Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier
- Digital Object Identifier
- https://doi.org/10.3233/JAD-210390
- Open Access
- https://aura.abdn.ac.uk/bitstreams/ef8b32b2-335b-468f-930e-a8e0751fbda2/download
- Additional Links
- View publication in Scopus